As filed with the Securities and Exchange Commission on March 21, 2023. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 _______________ Virax Biolabs Group Limited (Exact name of Registrant as specified in its charter) _______________ Not Applicable (Translation of Registrant's name into English) _______________ Cayman Islands 2835 Not Applicable (State or other jurisdiction of incorporat ...